109 related articles for article (PubMed ID: 26756900)
1. COX-2 inhibitor NS-398 suppresses doxorubicin-induced p53 accumulation through inhibition of ROS-mediated Jnk activation.
Kim J; Shim M
Mol Carcinog; 2016 Dec; 55(12):2156-2167. PubMed ID: 26756900
[TBL] [Abstract][Full Text] [Related]
2. Dexmedetomidine-induced contraction involves c-Jun NH2 -terminal kinase phosphorylation through activation of the 5-lipoxygenase pathway in the isolated endothelium-denuded rat aorta.
Ok SH; Byon HJ; Jin H; Kim HJ; Kim W; Nam IK; Eun SY; Sohn JT
Clin Exp Pharmacol Physiol; 2014 Dec; 41(12):1014-22. PubMed ID: 25224579
[TBL] [Abstract][Full Text] [Related]
3. Silibinin activated p53 and induced autophagic death in human fibrosarcoma HT1080 cells via reactive oxygen species-p38 and c-Jun N-terminal kinase pathways.
Duan WJ; Li QS; Xia MY; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2011; 34(1):47-53. PubMed ID: 21212516
[TBL] [Abstract][Full Text] [Related]
4. Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.
Ludke A; Akolkar G; Ayyappan P; Sharma AK; Singal PK
PLoS One; 2017; 12(7):e0179452. PubMed ID: 28678856
[TBL] [Abstract][Full Text] [Related]
5. The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis.
Ghosh J; Das J; Manna P; Sil PC
Biomaterials; 2011 Jul; 32(21):4857-66. PubMed ID: 21486680
[TBL] [Abstract][Full Text] [Related]
6. p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury.
Velez JM; Miriyala S; Nithipongvanitch R; Noel T; Plabplueng CD; Oberley T; Jungsuwadee P; Van Remmen H; Vore M; St Clair DK
PLoS One; 2011 Mar; 6(3):e18005. PubMed ID: 21479164
[TBL] [Abstract][Full Text] [Related]
7. BME, a novel compound of anthraquinone, down regulated P-glycoprotein expression in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells via generation of reactive oxygen species.
Wang J; Liu L; Cen J; Ji B
Chem Biol Interact; 2015 Sep; 239():139-45. PubMed ID: 26169035
[TBL] [Abstract][Full Text] [Related]
8. Eupafolin inhibits PGE2 production and COX2 expression in LPS-stimulated human dermal fibroblasts by blocking JNK/AP-1 and Nox2/p47(phox) pathway.
Tsai MH; Lin ZC; Liang CJ; Yen FL; Chiang YC; Lee CW
Toxicol Appl Pharmacol; 2014 Sep; 279(2):240-51. PubMed ID: 24967690
[TBL] [Abstract][Full Text] [Related]
9. P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK.
Fan S; Qi M; Yu Y; Li L; Yao G; Tashiro S; Onodera S; Ikejima T
Free Radic Res; 2012 Mar; 46(3):310-9. PubMed ID: 22283740
[TBL] [Abstract][Full Text] [Related]
10. The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells.
Elder DJ; Halton DE; Playle LC; Paraskeva C
Int J Cancer; 2002 May; 99(3):323-7. PubMed ID: 11992399
[TBL] [Abstract][Full Text] [Related]
11. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
12. Selective COX-2 inhibitors modulate cellular senescence in human dermal fibroblasts in a catalytic activity-independent manner.
Kim SR; Park JH; Lee ME; Park JS; Park SC; Han JA
Mech Ageing Dev; 2008 Dec; 129(12):706-13. PubMed ID: 18848576
[TBL] [Abstract][Full Text] [Related]
13. Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway.
Kim WH; Lee JW; Gao B; Jung MH
Cell Signal; 2005 Dec; 17(12):1516-32. PubMed ID: 15908180
[TBL] [Abstract][Full Text] [Related]
14. Nutlin-3 induces HO-1 expression by activating JNK in a transcription-independent manner of p53.
Choe YJ; Lee SY; Ko KW; Shin SJ; Kim HS
Int J Oncol; 2014 Mar; 44(3):761-8. PubMed ID: 24366007
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib induces heme-oxygenase expression in glomerular mesangial cells.
Hou CC; Hung SL; Kao SH; Chen TH; Lee HM
Ann N Y Acad Sci; 2005 May; 1042():235-45. PubMed ID: 15965068
[TBL] [Abstract][Full Text] [Related]
16. COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis.
Choi EM; Heo JI; Oh JY; Kim YM; Ha KS; Kim JI; Han JA
Biochem Biophys Res Commun; 2005 Mar; 328(4):1107-12. PubMed ID: 15707991
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of c-FLIP promotes caspase-dependent JNK activation and reactive oxygen species accumulation in tumor cells.
Nakajima A; Kojima Y; Nakayama M; Yagita H; Okumura K; Nakano H
Oncogene; 2008 Jan; 27(1):76-84. PubMed ID: 17599041
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine protects alveolar epithelial cells from hydrogen peroxide-induced apoptosis through scavenging reactive oxygen species and suppressing c-Jun N-terminal kinase.
Fu YQ; Fang F; Lu ZY; Kuang FW; Xu F
Exp Lung Res; 2010 Aug; 36(6):352-61. PubMed ID: 20653470
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway.
Yao Y; Chen R; Ying C; Zhang G; Rui T; Tao A
Biochem Biophys Res Commun; 2017 Nov; 493(3):1288-1295. PubMed ID: 28965952
[TBL] [Abstract][Full Text] [Related]
20. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.
Watanabe J; Nishiyama H; Matsui Y; Ito M; Kawanishi H; Kamoto T; Ogawa O
Oncogene; 2006 Apr; 25(17):2500-8. PubMed ID: 16518417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]